Brief: Inhibikase Therapeutics Announces Appointment Of David Mcintyre As CFO
14/04/2025 15:09
April 14 (Reuters) - Inhibikase Therapeutics Inc IKT.O: INHIBIKASE THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER INHIBIKASE THERAPEUTICS INC - APPOINTMENT OF DAVID MCINTYRE AS CHIEF FINANCIAL OFFICER, EFFECTIVE APRIL 14, 2025 Source text: ID:nGNX5q06tF Further company coverage: IKT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibikase Therapeutics
See all newsBrief: Inhibikase Therapeutics Prices Public Offering Of 46 Million Shares At $1.45 Per Share
Brief: Inhibikase Therapeutics Announces Proposed Public Offering Of Common Stock And Pre-Funded Warrants
Brief: Inhibikase Therapeutics Advancing IKT-001 To Global Phase 3 Study In Pulmonary Arterial Hypertension
Cardiopulmonary drugmaker Inhibikase Therapeutics' Q3 net loss widens
Inhibikase Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary